ELAN

17.81

2.18% 0.38

Handel nachbörslich: 17.81

Elanco Animal Health Inc (ELAN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$17.43

Offen:

$17.49

24-Stunden-Volumen:

5.58M

Relative Volume:

0.98

Marktkapitalisierung:

$8.85B

Einnahmen:

$4.45B

Nettoeinkommen (Verlust:

$205.00M

KGV:

44.52

EPS:

0.4

Netto-Cashflow:

$372.00M

1W Leistung:

+27.67%

1M Leistung:

+19.53%

6M Leistung:

+52.74%

1J Leistung:

+27.76%

1-Tages-Spanne:

$17.42

$17.83

1-Wochen-Bereich:

$15.50

$17.83

52-Wochen-Spanne:

$8.02

$17.83

Elanco Animal Health Inc Stock (ELAN) Company Profile

Firmenname

Elanco Animal Health Inc

Sektor

Healthcare (1161)

Branche

Drug Manufacturers - Specialty & Generic (84)

Telefon

877-352-6261

Adresse

2500 INNOVATION WAY, GREENFIELD

Mitarbeiter

9,450

Twitter

@Elanco

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

ELAN's Discussions on Twitter

Vergleichen Sie ELAN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ELAN Elanco Animal Health Inc	17.81	8.66B	4.45B	205.00M	372.00M	0.40
ZTS Zoetis Inc	152.44	66.38B	9.39B	2.62B	2.22B	5.81
TAK Takeda Pharmaceutical Co Adr	14.77	46.20B	29.96B	957.25M	5.31B	0.304
HLN Haleon Plc Adr	9.69	42.99B	14.26B	1.98B	0	0.4347
TEVA Teva Pharmaceutical Industries Ltd Adr	17.21	19.04B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	309.72	13.63B	2.99B	1.21B	1.13B	25.06

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-17	Hochstufung	Leerink Partners	Market Perform → Outperform
2025-06-26	Hochstufung	William Blair	Mkt Perform → Outperform
2024-12-09	Eingeleitet	UBS	Buy
2024-12-02	Eingeleitet	Leerink Partners	Market Perform
2024-09-19	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-01-05	Hochstufung	Stifel	Hold → Buy
2023-12-19	Eingeleitet	Jefferies	Buy
2023-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-12-07	Eingeleitet	Exane BNP Paribas	Outperform
2023-04-20	Hochstufung	Barclays	Equal Weight → Overweight
2022-08-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-08-16	Herabstufung	JP Morgan	Overweight → Neutral
2022-07-21	Herabstufung	Goldman	Buy → Sell
2022-07-12	Eingeleitet	Piper Sandler	Neutral
2021-11-18	Eingeleitet	Morgan Stanley	Overweight
2021-10-28	Herabstufung	Stifel	Buy → Hold
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-06-15	Hochstufung	Cleveland Research	Underperform → Neutral
2021-05-11	Hochstufung	Barclays	Underweight → Equal Weight
2021-05-11	Hochstufung	Gabelli & Co	Hold → Buy
2021-04-15	Eingeleitet	Stifel	Buy
2021-03-22	Herabstufung	Gabelli & Co	Buy → Hold
2021-02-26	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-09	Herabstufung	Argus	Buy → Hold
2020-11-09	Herabstufung	Barclays	Overweight → Underweight
2020-08-20	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-08-13	Fortgesetzt	Credit Suisse	Neutral
2020-08-04	Fortgesetzt	Goldman	Buy
2020-07-27	Herabstufung	Cleveland Research	Neutral → Underperform
2020-04-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-10	Eingeleitet	Raymond James	Mkt Perform
2019-12-19	Hochstufung	BofA/Merrill	Neutral → Buy
2019-11-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2019-09-23	Eingeleitet	Barclays	Overweight
2019-08-26	Herabstufung	BofA/Merrill	Buy → Neutral
2019-08-15	Hochstufung	UBS	Sell → Neutral
2019-05-23	Eingeleitet	Guggenheim	Neutral
2019-03-18	Hochstufung	BofA/Merrill	Neutral → Buy
2019-03-13	Fortgesetzt	Morgan Stanley	Equal-Weight
2019-02-12	Eingeleitet	William Blair	Mkt Perform
2019-01-23	Eingeleitet	UBS	Sell
2019-01-15	Eingeleitet	Argus	Buy
2018-10-15	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten

11:23 AM

Elanco spearheads Nutrition Secure Indianapolis initiative to provide food aid - Inside INdiana Business

11:23 AM

07:18 AM

Dogs Vaccines Market Exclusive Report with Detailed Study - openPR.com

07:18 AM

Aug 12, 2025

Elanco Animal Health Posts Robust Q2 Earnings, Exceeds Guidance with Strong Organic Growth and Innovation - AInvest

Aug 12, 2025

Elanco’s Q2 2025 Return to Profitability Signals Growth - Zenopa

Aug 12, 2025

Leerink Partners Keeps Buy Rating on Elanco Animal Health with $20 Price Target - AInvest

Aug 12, 2025

ELAN Q2 Deep Dive: Innovation and Execution Drive Raised Full-Year Outlook - FinancialContent

Aug 12, 2025

Aug 11, 2025

Elanco Animal Health (NYSE:ELAN) Releases Q3 2025 Earnings Guidance - MarketBeat

Aug 11, 2025

Price Consolidation Hints at Upcoming Move in Elanco Animal Health IncorporatedReversal Alert Based on RSI Indicator Confirmed - metal.it

Aug 11, 2025

Aug 09, 2025

Elanco (ELAN) Jumps 19.7% to Record High on Earnings Boost - MSN

Aug 09, 2025

Elanco Animal Health Surges 9% on Q2 Results and Optimistic Full-Year Forecast - AInvest

Aug 09, 2025

Elanco Animal Health: Analyst Sentiment Analysis and 12-Month Price Targets - AInvest

Aug 09, 2025

Elanco Animal Health Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Aug 09, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 09, 2025

Elanco Animal Health (ELAN) Gets a Buy from Bank of America Securities - The Globe and Mail

Aug 09, 2025

Elanco Animal Health Reports Strong Q2 2025 Results - The Globe and Mail

Aug 09, 2025

Chart based analysis of Elanco Animal Health Incorporated trendsTrend Confirmation Scanner with Entry Focus - Newser

Aug 09, 2025

Aug 08, 2025

A Quick Look at Today's Ratings for Elanco Animal Health(ELAN.US), With a Forecast Between $15 to $21 - 富途牛牛

Aug 08, 2025

An Intrinsic Calculation For Elanco Animal Health Incorporated (NYSE:ELAN) Suggests It's 36% Undervalued - Yahoo Finance

Aug 08, 2025

Elanco Animal Health shares fall 1.40% premarket after beating Q2 revenue estimates and raising FY guidance. - AInvest

Aug 08, 2025

What institutional flow reveals about Elanco Animal Health IncorporatedStrong Buy Signal Summary with Entry Zone - Newser

Aug 08, 2025